A deep intronic <i>PHEX</i> variant associated with X-linked hypophosphatemia in a Finnish family

Hypophosphatemic rickets is a rare bone disease characterized by short stature, bone deformities, impaired bone mineralization, and dental problems. Most commonly, hypophosphatemic rickets is caused by pathogenic variants in the X-chromosomal <i>PHEX</i> gene, but autosomal dominant and recessive forms also exist. We investigated a Finnish family in which the son (index, 29 yr) and mother (56 yr) had hypophosphatemia since childhood. Both patients had typical clinical, radiographic, and biochemical features of hypophosphatemic rickets, including a pathological fracture in the son. Gene panels and whole-exome sequencing did not reveal any pathogenic variants in the known hypophosphatemia genes. Therefore, we performed whole genome sequencing and identified a deep intronic variant (c.2147 + 1197A > G) in <i>PHEX</i>. Both the affected individuals, but none of the unaffected family members, had the same variant, as confirmed by Sanger sequencing. According to RT-PCR, whole transcriptomic data, and in silico analyses, the variant led to a new splice donor site in intron 21 and an 84 basepair pseudoexon between exons 21 and 22, likely leading to the synthesis of abnormal PHEX protein. Our study underscores the importance of intronic <i>PHEX</i> variants in X-linked hypophosphatemia (XLH). In patients with features of XLH but negative gene panel or whole-exome sequencing results, the combination of whole-genome sequencing and whole transcriptomics should be considered to detect possible deep intronic variants. The methodologies presented have the potential to be used more widely in other rare diseases.

Authors

Institutions

Publication Details

Journal
JBMR Plus
Published
2024-12-23
DOI
https://doi.org/10.1093/jbmrpl/ziae169
Citations
2
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.68

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A deep intronic PHEX variant associated with X-linked hypophosphatemia in a Finnish family

Salla Rusanen, Jelmer Legebeke, Mari Muurinen, Minna Pekkinen et al.
2 citations
JBMR Plus
Parathyroid Disorders and Treatments
0.68
article

A deep intronic PHEX variant associated with X-linked hypophosphatemia in a Finnish family

Salla Rusanen, Jelmer Legebeke, Mari Muurinen, Minna Pekkinen, Laura Koljonen, Outi Mäkitie, Pasi I. Nevalainen, Shabir Hussain, Fan Wang
article en
2 citations

Abstract

Hypophosphatemic rickets is a rare bone disease characterized by short stature, bone deformities, impaired bone mineralization, and dental problems. Most commonly, hypophosphatemic rickets is caused by pathogenic variants in the X-chromosomal <i>PHEX</i> gene, but autosomal dominant and recessive forms also exist. We investigated a Finnish family in which the son (index, 29 yr) and mother (56 yr) had hypophosphatemia since childhood. Both patients had typical clinical, radiographic, and biochemical features of hypophosphatemic rickets, including a pathological fracture in the son. Gene panels and whole-exome sequencing did not reveal any pathogenic variants in the known hypophosphatemia genes. Therefore, we performed whole genome sequencing and identified a deep intronic variant (c.2147 + 1197A > G) in <i>PHEX</i>. Both the affected individuals, but none of the unaffected family members, had the same variant, as confirmed by Sanger sequencing. According to RT-PCR, whole transcriptomic data, and in silico analyses, the variant led to a new splice donor site in intron 21 and an 84 basepair pseudoexon between exons 21 and 22, likely leading to the synthesis of abnormal PHEX protein. Our study underscores the importance of intronic <i>PHEX</i> variants in X-linked hypophosphatemia (XLH). In patients with features of XLH but negative gene panel or whole-exome sequencing results, the combination of whole-genome sequencing and whole transcriptomics should be considered to detect possible deep intronic variants. The methodologies presented have the potential to be used more widely in other rare diseases.

JBMR PlusVol. 9(2)
Karolinska University Hospital (SE), University of Helsinki (FI), Helsinki University Hospital (FI), Karolinska Institutet (SE), Tampere University Hospital (FI), Tampere University (FI), Institute for Molecular Medicine Finland (FI), Folkhälsans Forskningscentrum (FI)
Folkhälsanin Tutkimussäätiö, Academy of Finland, Suomen Kulttuurirahasto, Novo Nordisk, Stockholms Läns Landsting, Vetenskapsrådet, Emil Aaltosen Säätiö, Samfundet Folkhälsan, Lastentautien Tutkimussäätiö, Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, Sigrid Juséliuksen Säätiö, Orionin Tutkimussäätiö, Novo Nordisk Fonden, Stockholm läns landsting
Good health and well-being
Openalex Percentile: Top 25%
Parathyroid Disorders and Treatments
0.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.